Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Tevogen Bio Holdings Inc. has announced its new AI initiative, Tevogen.AI, in collaboration with Microsoft and Databricks to enhance immunotherapy development.
AIxMed and Lumea have announced a partnership to integrate AIxMed's AI technology into Lumea's digital pathology platform, enhancing bladder cancer diagnostics.
Illinois is on the verge of becoming the first state to regulate AI tools in mental health care with the WOPR Act, which prohibits unlicensed AI chatbots from providing therapy services.
Fresenius Medical Care presented its latest research and innovations in kidney care at the European Renal Association Congress 2025, showcasing advancements in clinical care and AI applications.
Outcomes4Me has raised $21 million to expand its AI-driven cancer care platform, with new investment from Salica Investments and existing backers like Labcorp Venture Fund.
Illumina has unveiled PromoterAI, an AI algorithm designed to identify pathogenic genetic variants in noncoding regions of the genome, enhancing rare disease diagnosis.
Nordic has joined the ServiceNow Partner and Reseller Programs to expand AI-driven solutions for healthcare organizations, announced in a press release.
Mapmygenome has acquired Microbiome Insights, enhancing its capabilities in microbial sequencing and expanding its presence in North America.
Simplex Quantum has been selected for the MedTech Innovator Asia Pacific 2025 Accelerator, recognizing its AI-powered heart failure detection technology among the top 20 MedTech startups in the region.
Lumeris has announced a partnership with MIT's Computational Biology Lab to enhance its AI platform, Tom, for primary care services.
Medsi AI's platform has been approved as the first Class II Software as a Medical Device (SaMD) for preventive health in the Western Hemisphere, according to a press release. This approval by COFEPRIS allows smartphones to be used as medical diagnostic tools.
Brainomix presented new studies at the European Stroke Organisation Conference, showcasing the effectiveness of its Brainomix 360 Stroke AI imaging solution in increasing mechanical thrombectomy rates.
Qualifyze has introduced the Quality Insights Platform, an AI-driven tool designed to enhance supplier site risk management for the pharmaceutical industry, announced in a press release.
Diagnostics.ai has introduced the first CE-IVDR certified AI platform for molecular diagnostics, offering transparency and compliance with EU regulations.
Minset has announced a seed funding round led by HealthX Ventures to scale its AI platform for healthcare revenue cycle management.
Biotia's BIOTIA-DX Resistance tool achieved the highest prediction accuracy at the CAMDA 2025 Antimicrobial Resistance Challenge, showcasing its advanced capabilities in genomics and AI.
Retrieve Medical Holdings and MyID have announced a joint venture to introduce the first wearable device with a complete electronic health record, combining AI technology with wearable tech.
PhaseV has announced a partnership with the Crohn's & Colitis Foundation to enhance IBD research using AI and machine learning, as stated in a press release.
Novellia has announced Project EVEREST, an AI-powered initiative to enhance breast cancer treatment adherence, supported by Daiichi Sankyo, Genentech, and AstraZeneca.
Arkstone Medical Solutions has published a study demonstrating the effectiveness of its AI-driven clinical decision support system in treating bacteremia, reducing treatment recommendation time by 29 hours.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
